tiprankstipranks
Advertisement
Advertisement

BAT Reaffirms 2026 Outlook as It Leans Further Into Smokeless Products

Story Highlights
  • BAT is intensifying its move from cigarettes to smokeless nicotine products, with brands like Vuse, glo and Velo driving a growing share of revenue and supporting its long-term sustainability and harm-reduction strategy.
  • At the CAGNY investor conference, BAT reaffirmed that its 2026 results should land at the lower end of its guidance ranges, pointing to steady but restrained growth in revenue, adjusted operating profit and adjusted diluted earnings.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
BAT Reaffirms 2026 Outlook as It Leans Further Into Smokeless Products

Meet Samuel – Your Personal Investing Prophet

British American Tobacco ( (GB:BATS) ) has issued an update.

British American Tobacco, a leading global nicotine consumer goods company, is accelerating its shift from cigarettes to smokeless alternatives such as vapour, heated tobacco and oral nicotine pouches as part of a long-term sustainability strategy. Its flagship smokeless brands Vuse, glo and Velo now serve more than 31 million adult consumers and contributed 18.2% of group revenue in 2025, while the group continues to deepen its scientific and environmental commitments.

The company said its chief executive Tadeu Marroco and Reynolds American president David Waterfield will address investors at the Consumer Analyst Group of New York conference, where BAT is reaffirming its 2026 full-year outlook. Management expects to deliver constant-currency performance at the lower end of previously announced ranges, with modest single-digit growth in revenue, adjusted operating profit and adjusted diluted earnings per share, signalling steady but subdued momentum as it navigates the transition to reduced-risk products.

The most recent analyst rating on (GB:BATS) stock is a Buy with a £52.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.

Spark’s Take on GB:BATS Stock

According to Spark, TipRanks’ AI Analyst, GB:BATS is a Outperform.

The score is driven primarily by solid-but-not-clean financial performance (profitability strength offset by leverage and a notable 2025 cash-flow decline). Valuation is supportive due to the high dividend yield and moderate P/E, while technicals are broadly neutral. Earnings-call guidance and capital-return plans help, but are tempered by vapor/illicit pressures and regional weakness.

To see Spark’s full report on GB:BATS stock, click here.

More about British American Tobacco

British American Tobacco is a global consumer goods group focused on nicotine products, spanning traditional cigarettes and a fast-growing portfolio of smokeless alternatives such as vapour, heated tobacco and modern oral nicotine pouches. The company, which generated £25.6bn in revenue in 2025 and employs more than 47,000 people, is targeting 50 million adult users of its smokeless products by 2030 and aims for these offerings to contribute half of group revenue by 2035.

Its key smokeless brands Vuse, glo and Velo had over 31 million adult consumers as of the end of 2025, accounting for 18.2% of group revenue and underscoring BAT’s strategic pivot away from combustible products. Alongside portfolio transformation, BAT is investing heavily in scientific research and has earned top-tier environmental ratings, including a recent Triple A from CDP for climate, water and forest disclosures, to reinforce its sustainability and harm-reduction credentials.

Average Trading Volume: 4,246,695

Technical Sentiment Signal: Strong Buy

Current Market Cap: £94.42B

For detailed information about BATS stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1